Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

InMed Pharmaceuticals Inc INM

InMed Pharmaceuticals Inc. is a pharmaceutical company. It develops a pipeline of small molecule drug candidates targeting the CB1/CB2 receptors. Its InMed Pharmaceuticals segment is engaged in the research and development of small molecule pharmaceuticals drug candidates. Its BayMedica Commercial segment is engaged in the manufacturing technologies to produce and commercialize bulk rare cannabinoids for sale as ingredients in the health and wellness industry. Its pharmaceutical pipeline consists of three programs, with drug candidates targeting Alzheimer’s disease, dry age-related macular degeneration, and Epidermolysis Bullosa. Its INM-901 is a drug candidate being developed as a potential treatment for Alzheimer’s disease. Its INM-089 is cannabinoid analog being studied for its potential as a treatment for age-related macular degeneration. Its INM-755 is a cannabinol topical cream which has completed Phase 2 clinical trial studies for the treatment of epidermolysis bullosa.


NDAQ:INM - Post by User

Comment by Bullknit101on Jan 02, 2021 3:33pm
144 Views
Post# 32209899

RE:RE:RE:RE:RE:Smart Money Accumulating ?

RE:RE:RE:RE:RE:Smart Money Accumulating ? Stevemin, I won't speak for Sarkazoo but I do appreciate a different perspective from folks like you and of course, if InMed is not a stock you recommend, would appreciate to hear what stocks you are bullish about. I disagree with your point of view on InMed but we can discuss the facts as they arise. We have Roth Capital, Brookline, Eight Capital, Edison and CB1 Capital all involved (or were in involved with InMed's story) and losing money with retail investors. You have to be quite cynical to think InMed is a ruse in the industry. What do think InMed's endgame is? This is a nascent industry and InMed has only been operating for 5 years.
<< Previous
Bullboard Posts
Next >>